In a report released today, Yaron Werber from TD Cowen maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a price ...

Google DeepMind by Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) and BioNTech (NASDAQ:BNTX) are collaborating to develop AI lab ...

Provides updates on BioNTech’s strategy to scale and deploy AI-capabilities across the immunotherapy pipelineHighlights InstaDeep’s new near ...

BioNTech has been boosted a wave of enthusiasm over another company’s cancer drug, which has turned the biopharma industry ...

The newest update to the COVID-19 vaccine reached pharmacies as infections in Indiana began to rise. Members of our audience ...

The BioNTech SE ADR BNTX inched 0.49% higher to $118.22 Friday, on what proved to be an all-around mixed trading session for ...

Google is developing advanced AI reasoning software using 'chain-of-thought prompting' to solve complex problems in fields ...

In addition to writing… Google DeepMind and BioNTech are collaborating to create AI lab assistants aimed at improving ...

Pfizer and Moderna's legal battle over their rival COVID-19 vaccines will continue after London's High Court on Wednesday ...

Health Canada approved Pfizer-BioNTech’s updated COVID-19 vaccine on Tuesday, marking its third authorization of vaccine ...

AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...

BioNTech SE ADR closed $10.99 short of its 52-week high ($115.99), which the company reached on September 14th.